Bill U.

Bill U. has a diverse work experience in the pharmaceutical industry. Bill is currently working as the Director of Strategic Accounts at Intercept Pharmaceuticals since January 2023. Before that, they served as the Director of Market Access & Account Strategy at RedHill Biopharma Ltd. from June 2022 to January 2023. Prior to that, Bill worked as a National Account Executive - Market Access at RedHill Biopharma Ltd. from June 2020 to June 2022.

Earlier in their career, Bill was an Executive Corporate Account Manager - Market Access at LEO Pharma from an unspecified start date in 2011 until June 2020. Before that, they worked as a National Account Manager - Managed Care at Nipro Diagnostics (formerly Home Diagnostics) from an unspecified start date in 2007 to 2011.

Bill also has experience as a Senior Key Account Manager at Ferndale Laboratories, Inc. from January 2000 to an unspecified end date in 2007. Bill began their career as a Health Care Sales Representative at Wallace Computer Services, where they worked from an unspecified start date in 1998 until an unspecified end date in 2001.

Bill U. earned a Master of Science (MS) degree in Health Services Administration from Florida Gulf Coast University between 2010 and 2013. Prior to that, they attended Central Michigan University and received a BAA degree in Broadcasting, although the specific dates of their enrollment are unknown.